CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 215 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $945,674 | +0.4% | 34,710 | -18.0% | 0.09% | +1.2% |
| Q2 2023 | $942,288 | +9.3% | 42,350 | +6.4% | 0.09% | +1.2% |
| Q1 2023 | $862,068 | +6.6% | 39,800 | 0.0% | 0.08% | -2.3% |
| Q4 2022 | $808,338 | -20.8% | 39,800 | 0.0% | 0.09% | -27.5% |
| Q3 2022 | $1,020,000 | +7.8% | 39,800 | 0.0% | 0.12% | +15.4% |
| Q2 2022 | $946,000 | +5.6% | 39,800 | 0.0% | 0.10% | +19.5% |
| Q1 2022 | $896,000 | +13.7% | 39,800 | 0.0% | 0.09% | +24.3% |
| Q4 2021 | $788,000 | -11.0% | 39,800 | 0.0% | 0.07% | -23.1% |
| Q3 2021 | $885,000 | +1.0% | 39,800 | 0.0% | 0.09% | 0.0% |
| Q2 2021 | $876,000 | -7.5% | 39,800 | 0.0% | 0.09% | -35.0% |
| Q1 2021 | $947,000 | -9.0% | 39,800 | 0.0% | 0.14% | -15.7% |
| Q4 2020 | $1,041,000 | +50.2% | 39,800 | 0.0% | 0.17% | +32.8% |
| Q3 2020 | $693,000 | +3.6% | 39,800 | 0.0% | 0.12% | -6.0% |
| Q2 2020 | $669,000 | +41.4% | 39,800 | 0.0% | 0.13% | +17.7% |
| Q1 2020 | $473,000 | -1.9% | 39,800 | 0.0% | 0.11% | +18.9% |
| Q4 2019 | $482,000 | -14.4% | 39,800 | 0.0% | 0.10% | -18.1% |
| Q3 2019 | $563,000 | +26.8% | 39,800 | 0.0% | 0.12% | +28.9% |
| Q2 2019 | $444,000 | -4.9% | 39,800 | 0.0% | 0.09% | -6.2% |
| Q1 2019 | $467,000 | -12.2% | 39,800 | 0.0% | 0.10% | -21.3% |
| Q4 2018 | $532,000 | -4.7% | 39,800 | 0.0% | 0.12% | +8.0% |
| Q3 2018 | $558,000 | -10.9% | 39,800 | 0.0% | 0.11% | -8.9% |
| Q2 2018 | $626,000 | -4.4% | 39,800 | 0.0% | 0.12% | -8.1% |
| Q1 2018 | $655,000 | -8.9% | 39,800 | 0.0% | 0.14% | -7.5% |
| Q4 2017 | $719,000 | -6.4% | 39,800 | 0.0% | 0.15% | -11.0% |
| Q3 2017 | $768,000 | +63.4% | 39,800 | 0.0% | 0.16% | +51.9% |
| Q2 2017 | $470,000 | +7.8% | 39,800 | 0.0% | 0.11% | 0.0% |
| Q1 2017 | $436,000 | +50.9% | 39,800 | 0.0% | 0.11% | +35.0% |
| Q4 2016 | $289,000 | +95.3% | 39,800 | +74.6% | 0.08% | +90.5% |
| Q3 2016 | $148,000 | +19.4% | 22,800 | 0.0% | 0.04% | +13.5% |
| Q2 2016 | $124,000 | +15.9% | 22,800 | 0.0% | 0.04% | 0.0% |
| Q1 2016 | $107,000 | – | 22,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,825,262 | $138,621 | 7.54% |
| Novo Holdings A/S | 3,377,768 | $68,602,468 | 4.28% |
| Parallel Advisors, LLC | 3,724,664 | $75,647,926 | 3.28% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $722 | 2.29% |
| Quantedge Capital Pte Ltd | 251,312 | $5,104,147 | 1.71% |
| S&T BANK/PA | 346,306 | $7,033 | 1.30% |
| Freshford Capital Management, LLC | 249,000 | $5,057,190 | 1.09% |
| Birchview Capital, LP | 50,000 | $1,016 | 0.72% |
| FAS Wealth Partners, Inc. | 306,276 | $6,220,466 | 0.70% |
| Bridge City Capital, LLC | 60,824 | $1,235 | 0.63% |